# A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

> **NCT00660829** · PHASE3 · COMPLETED · sponsor: **Meda Pharmaceuticals** · enrollment: 536 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Placebo
- **DRUG:** 0.15% Azelastine Hydrochloride

## Key facts

- **NCT ID:** NCT00660829
- **Lead sponsor:** Meda Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-02
- **Final completion:** 2008-04
- **Target enrollment:** 536 (ACTUAL)
- **Last updated:** 2015-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00660829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00660829, "A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00660829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*